References
- American Cancer Society. Breast Cancer Facts & Figures 2005–2006. American Cancer Society, Inc., GA, USA.
- Hollingsworth A. The truth about breast cancer risk assessment. The National Writer’s Press, Aurora, CO, USA 5 (2000).
- Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N. Engl. J. Med.356(23), 2388–2398 (2007).
- Hartmann LC, Sellers TA, Frost MA et al. Benign breast disease and the risk of breast cancer. N. Engl. J. Med.353(3), 229–237 (2005).
- Fabian C, Kimmler B. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J. Natl Cancer Inst.92(15), 1217–1227 (2000).
- Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med.353, 1784–1792 (2005).
- Buist DS, Porter PL, Lehman C et al. Factors contributing to mammography failure in women aged 40–49 years. J. Natl Cancer Inst.96(19), 1432–1440 (2004).
- MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet365, 1769–1778 (2005).
- Saslow D, Boetes C, Burke W et al. American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin.57, 75–89 (2007).
- Fisher B, Costantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst.90(18), 1371–1388 (1998).
- Malone KE, Daling JR, Doody DR et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res.66, 8297–8308 (2006).
- Wrensch MR, Petrakis NL, Miike R et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. J. Natl Cancer Inst.93(23), 1791–1798 (2001).
- Proctor KAS, Rowe LR, Bentz JS. Cytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational study. BMC Womens Health.5(10), 1–14 (2005).
- Lee WY. Cytology of abnormal nipple discharge: a cyto-histological correlation. Cytopathologyh.14, 19–26(2003).
- Zabicki K, Colbert JA, Dominguez FJ et al. Breast cancer diagnosis in women <40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann. Surg. Oncol.13, 1072–1077 (2006).
- Dupont WD, Parl FF, Hartmann WH et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer71(4), 1258–1265 (2006).
- Hollingsworth AB, Singletary SE, Morrow M et al. Current comprehensive assessment and management of women at increased risk for breast cancer. Am. J. Surg.187, 349–362 (2004).
- Alexander H, Stegner AL, Wagner-Mann C et al. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin. Cancer Res.10, 7500–7510 (2004).
Websites
- American Cancer Society. Cervical cancer: prevention and early detection. www.cancer.org/docroot/cri/content/cri_2_6x_cervical_cancer_prevention_and_early_detection_8.asp
- National Cancer Institute. Cervical cancer screening.www.cancer.gov/cancertopics/pdq/screening/cervical/healthprofessional/page4
- The American Society of Breast Surgeons – Official Statements.www.breastsurgeons.org/officialstmts/officialstmt4.shtml